CD BioGlyco is a leading global biology company, and we are committed to providing the most comprehensive and high-quality one-stop customized services in the field of cancer glucose metabolism.
Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM) is a dedicated cancer glucose metabolism profiling platform. Based on multi-omics technologies such as genomics, proteomics, and metabolomics, it provides quantitative analysis and functional analysis of glucose metabolites at the cell, tissue, and animal levels during the whole process of cancer progression, metabolic enzyme expression and activity detection, and glucose metabolism, flux analysis. We expect to provide a full range of services for cancer glucose metabolism research and promote the application of cancer glucose metabolism research in the fields of cancer prevention, diagnosis and treatment.
We provide comprehensive services covering genomics, metabolomics, proteomics, and metabolic fluxomics.
A multi-omics platform dedicated to providing cancer glucose metabolism research services.
We provide personalized service based on the customers' research priorities.
Leveraging four unique cancer omics technology to change the paradigm of cancer glucose metabolism research.
Guide cancer research with multi-omics data on cancer glucose metabolism, and find the intervention method of glucose metabolism to cure cancer.
Fluxomics in cancer glucose metabolism that the concentration of intermediate metabolites in cancer cells remains unchanged for a certain period of time, and accurately analyzes the characterization of cancer glucose metabolism based on the quantitative relationship of each reaction in the metabolic pathway and the experimentally measured substrate consumption rate
Metabolomics in cancer glucose metabolism uses chromatography, mass spectrometry, and other techniques to quantitatively analyze all glucose metabolites in cancer cells to find the relationship between cancer glucose metabolism and cancer progression.
Proteomics in cancer glucose metabolism takes the proteins involved in the process of glucose metabolism reprogramming in cancer cells as research objects and conducts quantitative analysis, localization analysis, post-translational modification analysis, and protein interaction analysis.
Genomics in cancer glucose metabolism studies cancer glucose metabolism-related genes through high-throughput sequencing and bioinformatics. Unraveling the mystery of the reprogramming of cancer glucose metabolism through the study of cancer glucose metabolism genomics.
If you are interested in our services, please contact us for more detailed information.